- Home
- SAR vs CCCC Comparison
SAR vs CCCC Comparison
Compare SAR & CCCC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SAR
- CCCC
- Stock Information
- Founded
- SAR 2007
- CCCC 2015
- Country
- SAR United States
- CCCC United States
- Employees
- SAR N/A
- CCCC N/A
- Industry
- SAR Investment Managers
- CCCC Biotechnology: Pharmaceutical Preparations
- Sector
- SAR Finance
- CCCC Health Care
- Exchange
- SAR Nasdaq
- CCCC Nasdaq
- Market Cap
- SAR 331.7M
- CCCC 396.0M
- IPO Year
- SAR 2007
- CCCC 2020
- Fundamental
- Price
- SAR $25.70
- CCCC $4.01
- Analyst Decision
- SAR Buy
- CCCC Buy
- Analyst Count
- SAR 4
- CCCC 6
- Target Price
- SAR $25.42
- CCCC $10.00
- AVG Volume (30 Days)
- SAR 63.7K
- CCCC 1.0M
- Earning Date
- SAR 01-07-2025
- CCCC 10-31-2024
- Dividend Yield
- SAR 11.50%
- CCCC N/A
- EPS Growth
- SAR N/A
- CCCC N/A
- EPS
- SAR 1.57
- CCCC N/A
- Revenue
- SAR $155,255,243.00
- CCCC $33,668,000.00
- Revenue This Year
- SAR $5.75
- CCCC $76.74
- Revenue Next Year
- SAR N/A
- CCCC N/A
- P/E Ratio
- SAR $16.39
- CCCC N/A
- Revenue Growth
- SAR 20.62
- CCCC 65.45
- 52 Week Low
- SAR $21.56
- CCCC $1.06
- 52 Week High
- SAR $27.00
- CCCC $11.88
- Technical
- Relative Strength Index (RSI)
- SAR 71.56
- CCCC 27.45
- Support Level
- SAR $24.52
- CCCC $3.84
- Resistance Level
- SAR $25.68
- CCCC $6.20
- Average True Range (ATR)
- SAR 0.37
- CCCC 0.49
- MACD
- SAR 0.14
- CCCC -0.19
- Stochastic Oscillator
- SAR 92.38
- CCCC 6.34
About SAR Saratoga Investment Corp New
Saratoga Investment Corp is a specialty finance company that provides customized financing solutions to U.S. middle-market businesses. The Company invests primarily in senior and unitranche leveraged loans and mezzanine debt, and, to a lesser extent, equity to provide financing for change of ownership transactions, strategic acquisitions, recapitalizations and growth initiatives in partnership with business owners, management teams and financial sponsors. Its objective is to create attractive risk-adjusted returns by generating current income and long-term capital appreciation from its debt and equity investments.
About CCCC C4 Therapeutics Inc.
C4 Therapeutics Inc is a biopharmaceutical company advancing targeted protein degradation science to develop a new generation of small-molecular medicines to transform how the disease is treated. Its TORPEDO platform enables the discovery of a new class of targeted investigational small-molecule medicines called protein degraders.